Physician profile
Patrick Lombardi
NPI 1750825725
$17,631.76
in general payments reported to CMS, 2019-2025
27 companies · $4,135 in 2025
The $4,135 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $505 · 2022: $2,358 · 2023: $4,825 · 2024: $5,808 · 2025: $4,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $1,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,968.50 |
| Consulting Fee | $1,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,499.74 | 2022-2025 | |
| Incyte Corporation | $2,474.97 | 2021-2025 | Opzelura, Opzelura |
| Amgen INC. | $2,075.47 | 2022-2025 | Otezla, Otezla, Enbrel |
| Novartis Pharmaceuticals Corporation | $1,545.97 | 2021-2025 | |
| Leo Pharma INC. | $1,442.90 | 2021-2025 | Adbry, Anzupgo |
| Janssen Biotech, INC. | $968.23 | 2022-2025 | Tremfya, Simponi Aria, Stelara |
| Genzyme Corporation | $915.91 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $856.41 | 2023-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $768.16 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $591.08 | 2022-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $526.20 | 2021-2025 | Winlevi, Blu-U, Odomzo |
| Ucb, INC. | $466.07 | 2022-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $455.00 | 2023-2025 | |
| Journey Medical Corporation | $426.22 | 2022-2025 | |
| Galderma Laboratories, L.P. | $318.28 | 2023-2025 | Nemluvio, Aklief, Epsolay |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $274.39 | 2023-2024 | Ycanth |
| Lilly USA, LLC | $184.46 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Epi Health, LLC | $162.69 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $160.56 | 2021-2024 | Jublia, Arazlo, Cabtreo |
| Almirall LLC | $138.73 | 2022 | |
| Dermavant Sciences, INC. | $127.22 | 2023-2024 | Vtama |
| Mayne Pharma Commercial LLC | $74.72 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $72.00 | 2022 | |
| Janssen Scientific Affairs, LLC | $29.08 | 2023 | Tremfya |
| Medline Industries LP | $28.75 | 2024 | |
| Alk-Abello, INC | $27.98 | 2021 | |
| Organogenesis INC. | $20.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Lombardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.